These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 3292144

  • 1. Blood pressure changes during treatment with recombinant human erythropoietin.
    Samtleben W, Baldamus CA, Bommer J, Fassbinder W, Nonnast-Daniel B, Gurland HJ.
    Contrib Nephrol; 1988; 66():114-22. PubMed ID: 3292144
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
    Kühn K, Nonnast-Daniel B, Grützmacher P, Grüner J, Pfåffl W, Baldamus CA, Scigalla P.
    Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152
    [No Abstract] [Full Text] [Related]

  • 3. Beneficial and adverse effects of correction of anaemia by recombinant human erythropoietin in patients on maintenance haemodialysis.
    Grützmacher P, Bergmann M, Weinreich T, Nattermann U, Reimers E, Pollok M.
    Contrib Nephrol; 1988; 66():104-13. PubMed ID: 3292143
    [No Abstract] [Full Text] [Related]

  • 4. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
    Bommer J, Kugel M, Schoeppe W, Brunkhorst R, Samtleben W, Bramsiepe P, Scigalla P.
    Contrib Nephrol; 1988; 66():85-93. PubMed ID: 3292151
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of erythropoietin treatment on O2 affinity and performance in patients with renal anemia.
    Böcker A, Reimers E, Nonnast-Daniel B, Kühn K, Koch KM, Scigalla P, Braumann KM, Brunkhorst R, Böning D.
    Contrib Nephrol; 1988; 66():165-75. PubMed ID: 3391031
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Recombinant erythropoietin for the anemia of chronic renal failure.
    Ahmad R, Hand M.
    N Engl J Med; 1987 Jul 16; 317(3):169-70. PubMed ID: 3600706
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Erythropoietin for anemia of renal failure in sickle cell disease.
    Steinberg MH.
    N Engl J Med; 1991 May 09; 324(19):1369-70. PubMed ID: 1759999
    [No Abstract] [Full Text] [Related]

  • 18. Side effects of erythropoietin therapy.
    Bennett WM.
    Am J Kidney Dis; 1991 Oct 09; 18(4 Suppl 1):84-6. PubMed ID: 1928085
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lymphocyte subsets and delayed cutaneous hypersensitivity in hemodialysis patients receiving recombinant human erythropoietin.
    Pfåffl W, Gross HJ, Neumeier D, Nattermann U, Samtleben W, Gurland HJ.
    Contrib Nephrol; 1988 Oct 09; 66():195-204. PubMed ID: 3391032
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.